Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults
Drug Design, Development and Therapy · 2025-03 · Volume 19 · 1503-1514
DOI: 10.2147/dddt.s488414 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2025-03. Verfasst von Zhu Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China. Hauptthemen laut MEDLINE: Anticoagulants. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Trial Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
- Department of Hematology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
- Johnson & Johnson, Shanghai, People's Republic of China.
- Johnson & Johnson, Beijing, People's Republic of China.
- Johnson & Johnson, Raritan, NJ, USA.
ORCID-Profile: Jie Wang, Cuili Hu, Peter Zannikos
Zitieren
APA
Luo, Z., Wang, J., Niu, Z., Hu, C., Chintala, M., Luo, X., Lee, T. I., Plotnikov, A. N., & Zannikos, P. (2025). Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults. Drug Design, Development and Therapy, Volume 19, 1503-1514. https://doi.org/10.2147/dddt.s488414
Vancouver
Luo Z, Wang J, Niu Z, Hu C, Chintala M, Luo X, et al. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults. Drug Design, Development and Therapy. 2025;Volume 19:1503-1514. doi:10.2147/dddt.s488414
BibTeX
@article{Luo2025,
author = {Luo, Zhu and Wang, Jie and Niu, Zhuolu and Hu, Cuili and Chintala, Madhu and Luo, Xinchao and Lee, Tsung-I and Plotnikov, Alexei N and Zannikos, Peter},
title = {Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Milvexian in Healthy Chinese Adults},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {1503--1514},
doi = {10.2147/dddt.s488414}
}
EUVIMED